Skip to content
Stock overview

HRMY · Harmony Biosciences Holdings, Inc.

Is HRMY setting up for a breakout, what are traders on X and the news saying, are its insiders buying, and how is the business doing? Everything Raspberry Trades measures on Harmony Biosciences Holdings, Inc., in one place.

Today's breakout radar

Is HRMY setting up for a breakout?

Breakout Radar API →

HRMY reports earnings on Nov 4, 2026 — a breakout right before a report can reverse on the numbers.

Not today. HRMY is not on today's radar: no tight base just under a resistance that has been tested again and again.

See the stocks that are setting up today →

What are traders on X saying about HRMY?

Stock Sentiment API →
Bullish
Overall
2
Bullish posts
0
Bearish posts
3
Posts read

Bulls: BlackRock Inc raised its stake in HRMY to 7.36M shares from 6.53M, lifting its ownership to 12.6%. The position increase by a major institutional holder coincides with reports that Harmony is drawing investor interest on strong growth.

Reading from Oct 28, 2026; each post classified by AI, weighted by engagement.

X sentiment, day by day (28 days measured)Sentiment History API →
Sep 17, 2026above the line = more bullish than bearishOct 28, 2026

What is the news saying about HRMY?

News Sentiment API →

No recent news reading for HRMY. The News Sentiment API reads today's headlines on any US stock.

Are HRMY insiders buying or selling?

Insider Trading API →
$0
Bought, last 3 months
$3.1M
Sold, last 3 months
$0
Bought, 12 months
$6.0M
Sold, 12 months

Open-market trades only, from SEC Form 4 filings — option exercises, tax withholding and grants are left out.

  • Sold · Budur Kumar$1.5M · Sep 18, 2026
  • Sold · Budur Kumar$34K · Sep 17, 2026
  • Sold · Budur Kumar$77K · Sep 16, 2026
  • Sold · Budur Kumar$989K · Sep 8, 2026
  • Sold · Budur Kumar$43K · Sep 8, 2026
Every HRMY insider trade →

How is Harmony Biosciences Holdings, Inc.'s business doing?

Financial Statements API →
Quarter endedRevenuevs year beforeNet incomeEPS
Jun 30, 2026$261.3M+30%$75.4M$1.28
Mar 31, 2026$215.4M+17%$32.5M$0.55
Sep 30, 2025$239.5M+29%$50.9M$0.87
Jun 30, 2025$200.5M+16%$39.8M$0.68

From the company's SEC filings (10-Q and 10-K).

What does Harmony Biosciences Holdings, Inc. expect?

Company Guidance API →
  • Full year 2026 · wakix net revenue · 8-K filed Aug 4, 2026

    “Reiterated 2026 WAKIX net revenue guidance of $1.0 billion to $1.04 billion .”

  • Full-Year 2026 · net revenue · 8-K filed Jul 16, 2026

    “Reaffirms 2026 Net Revenue Guidance of $1.0 Billion to $1.04 Billion”

  • Full year ending December 31, 2026 · wakix net revenue · 8-K filed May 7, 2026

    “Reiterated 2026 WAKIX Net Revenue Guidance of $1.0 Billion – $1.04 Billion”

  • 2026 · net product revenue · 8-K filed Apr 14, 2026

    “Harmony is also reiterating its 2026 net product revenue guidance of $1.0 to $1.04 billion.”

Quoted from the outlook the company filed with the SEC.

Get the best breakout setups every morning

Free account, no card: today's top 5 with charts, by email before the open.

Get the top 5 free

Measured data, not recommendations. Not investment advice.